Mersana Therapeutics Inc (MRSN)
2.725
+0.14
(+5.62%)
USD |
NASDAQ |
May 17, 16:00
2.725
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Cash from Financing (Quarterly): 1.645M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.645M |
| December 31, 2023 | 76.19M |
| September 30, 2023 | -3.061M |
| June 30, 2023 | -1.738M |
| March 31, 2023 | 23.28M |
| December 31, 2022 | 153.43M |
| September 30, 2022 | 2.481M |
| June 30, 2022 | -2.565M |
| March 31, 2022 | -0.329M |
| December 31, 2021 | 55.91M |
| September 30, 2021 | 2.478M |
| June 30, 2021 | 4.789M |
| March 31, 2021 | 0.472M |
| December 31, 2020 | 1.665M |
| September 30, 2020 | -0.049M |
| June 30, 2020 | 228.89M |
| March 31, 2020 | -0.09M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.231M |
| September 30, 2019 | -0.008M |
| June 30, 2019 | 5.277M |
| March 31, 2019 | 92.20M |
| December 31, 2018 | 0.211M |
| September 30, 2018 | 0.209M |
| June 30, 2018 | 0.389M |
| March 31, 2018 | 0.255M |
| December 31, 2017 | 0.021M |
| September 30, 2017 | 70.64M |
| June 30, 2017 | -1.664M |
| March 31, 2017 | -0.401M |
| December 31, 2016 | 0.024M |
| September 30, 2016 | -0.037M |
| June 30, 2016 | 58.24M |
| March 31, 2016 | 0.031M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.061M
Minimum
Sep 2023
228.89M
Maximum
Jun 2020
27.44M
Average
1.655M
Median
Cash from Financing (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -13.31M |
| Geron Corp | 147.80M |
| Insmed Inc | 3.022M |
| Altimmune Inc | -0.261M |
| InfuSystems Holdings Inc | 0.632M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.21M |
| Cash from Investing (Quarterly) | -4.266M |
| Free Cash Flow | -163.32M |
| Free Cash Flow Per Share (Quarterly) | -0.0035 |
| Free Cash Flow to Equity (Quarterly) | -0.498M |
| Free Cash Flow Yield | -50.04% |